Market Cap 898.05M
Revenue (ttm) 76.99M
Net Income (ttm) -174.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.74%
Debt to Equity Ratio 0.42
Volume 9,729,600
Avg Vol 16,569,707
Day's Range N/A - N/A
Shares Out 636.91M
Stochastic %K 73%
Beta 0.66
Analysts Strong Sell
Price Target $4.67

Latest News on GERN

Geron Corp: How Concerned Should We Be About Rytelo Sales?

Mar 17, 2025, 5:19 PM EDT - 5 weeks ago

Geron Corp: How Concerned Should We Be About Rytelo Sales?


Geron Corporation (GERN) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 11:31 AM EST - 2 months ago

Geron Corporation (GERN) Q4 2024 Earnings Call Transcript


3 Biotech/Healthcare Names Under $10 I Am Buying Now

Feb 21, 2025, 4:21 PM EST - 2 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

ARDX MRNA PSNL TEM